Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
2d
Incyte Announces Health Canada Approval of OPZELURA® (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD) and Nonsegmental Vitiligo
Incyte Biosciences Canada today announced that Health Canada has granted a Notice of Compliance for OPZELURA® (ruxolitinib ...
2d
Nodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunities
Nodenza Venture Partners launchedFocus on international early-stage and pre-commercial biotech & medtech opportunitiesNew York, October 16, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Judge unseals new evidence
Preliminary cause of death
School shooting report
La Nina could arrive soon
Nationwide blackout in Cuba
Three Americans detained
PG&E shuts off power
Republicans appeal ruling
NYC giant pigeon sculpture
NC breaks turnout record
Calif. oil refinery closure
OK classroom Bible suit
Fire prompts evacuations
NK sending troops to RU?
Lebanese citizens get TPS
Teen tobacco use falls
To furlough 700 workers
Eases voting rules
Ex-MN congressman dies
‘Full Self-Driving’ probe
Dow closes at record high
Nevada US Senate debate
School shooting indictment
$4M LAPD fentanyl seizure
Emergency abortion ruling
US charges ex-Indian spy
Sells for $9M at auction
At decade-high level
988 Lifeline georouting
Musk's first Trump event
Bladder cancer drug pulled
Space export curbs eased
Feedback